Citalopram/pipamperone
Citalopram/Pipamperone[edit]

Citalopram/pipamperone is a combination of two psychotropic medications used primarily in the treatment of depression and certain psychotic disorders. This combination leverages the antidepressant effects of citalopram with the antipsychotic properties of pipamperone.
Pharmacology[edit]
Citalopram[edit]
Citalopram is a selective serotonin reuptake inhibitor (SSRI) that is commonly prescribed for the treatment of major depressive disorder. It functions by increasing the levels of serotonin in the brain, which can improve mood and emotional stability. Citalopram is known for its relatively favorable side effect profile compared to older classes of antidepressants.
Pipamperone[edit]

Pipamperone is a typical antipsychotic belonging to the butyrophenone class. It is primarily used in the management of schizophrenia and other psychotic disorders. Pipamperone works by blocking dopamine receptors in the brain, which helps to reduce symptoms such as hallucinations and delusions.
Clinical Use[edit]
The combination of citalopram and pipamperone is utilized in cases where patients exhibit both depressive and psychotic symptoms. This dual-action approach can be beneficial in treating complex cases where a single medication may not be sufficient. The combination aims to address both mood stabilization and the reduction of psychotic symptoms.
Mechanism of Action[edit]
The mechanism of action for this combination involves the modulation of neurotransmitter systems in the brain. Citalopram increases serotonin levels, which can enhance mood and reduce anxiety, while pipamperone's antagonistic effects on dopamine receptors help to mitigate psychotic symptoms. Together, they provide a comprehensive approach to managing both depression and psychosis.
Side Effects[edit]
The side effects of citalopram/pipamperone can include those associated with each individual component. Common side effects of citalopram include nausea, dry mouth, and insomnia. Pipamperone may cause drowsiness, weight gain, and extrapyramidal symptoms. It is important for healthcare providers to monitor patients for any adverse effects and adjust treatment as necessary.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian